Hypothesis

Tau pathology in the medial amygdala impairs CRF‑neuron function rather than heightening it, leading to deficient fear‑extinction learning while sparing basal anxiety.

Mechanistic Rationale

It's known that aging‑related amygdala‑vPFC white‑matter decline correlates with trait anxiety, suggesting circuit uncoupling, and that focal tau in the medial amygdala associates with altered connectivity and anxiety symptoms. We propose that tau disrupts microtubule stability, impairing axonal transport of CRF‑containing vesicles and reducing CRF‑R1 signaling in local interneurons. This weakening of CRF‑dependent LTP undermines the synaptic plasticity needed for extinction memory formation. This weakening doesn't affect baseline anxiety, as parallel circuits such as the bed nucleus of the stria terminalis (BNST) or lateral amygdala retain intact glutamatergic transmission, preserving low baseline anxiety. Consequently, when tasks require integrated cortical‑amygdalic processing—such as discrimination of complex threat contexts—the hypo‑extinction circuit fails, producing context‑dependent hyperreactivity, yet overall anxious temperament remains low because baseline threat detection relies on non‑CRF pathways.

Testable Predictions

1. In aged mice, CRF‑neuron–specific tau overexpression will reproduce extinction deficits without raising baseline anxiety measures (elevated plus maze, open‑field).
2. Knocking down tau in CRF neurons of aged tauopathy models will rescue extinction learning while amygdala‑vPFC white‑matter integrity remains low.
3. Pharmacological enhancement of CRF‑R1 signaling (e.g., with a selective agonist) will restore extinction in aged animals only when CRF neurons are tau‑positive.
4. Chemogenetic silencing of BNST output will unmask heightened anxiety in aged mice with CRF‑neuron tau, revealing the compensatory role of this circuit.

Experimental Approach

• Use P301S tau transgenic mice crossed with a CRF‑Cre line to express either wild‑type tau or a tau‑targeting shRNA exclusively in CRF neurons; include littermate controls receiving a scrambled shRNA.
• Confirm tau accumulation and CRF‑neuron excitability via in‑vivo fiber photometry of GCaMP6f and ex‑vivo patch‑clamp recordings measuring input resistance and firing rates after corticotropin‑releasing hormone application.
• Conduct fear conditioning (tone‑shock pairing), followed by extinction training over two days; test extinction recall and renewal 24 h later. Quantify freezing percentages with automated video tracking.
• Measure anxiety‑like behavior in the elevated plus maze (time in open arms) and open field (center‑time distance) at matched ages.
• Acquire diffusion tensor imaging ex vivo; compute fractional anisotropy in the amygdala‑vPFC tract and correlate with behavioral scores.
• Employ DREADDs (hM4Di) to inhibit BNST projections to the central amygdala during extinction testing; assess whether blocking this compensatory route elevates anxiety indices.
• Perform statistical analysis using two‑way ANOVA (genotype × treatment) with post‑hoc Tukey tests; power analysis targets n = 12 per group to detect medium effect sizes (Cohen’s d = 0.5) at α = 0.05, power = 0.8.

If the data show that rescuing CRF‑neuron tau normalizes extinction without altering baseline anxiety or white‑matter integrity, the hypothesis gains support; conversely, if extinction remains impaired despite tau reduction or if BNST inhibition fails to affect anxiety, the proposed mechanism would be falsified.